Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Caring for our elders
This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...
Antimicrobial use up in disadvantaged areas
Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.
Young sparks light up pharmacy future
The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed.
Judges were...
Quick Q&A with Katherine Higgins MPS
Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.
Transforming medicine safety in aged care
PSA’s 2025 Early Career Pharmacist of the Year, Dr Kate Wang is shaping pharmacy education and aged care policy.


Deborah Williams at the Chemist Warehouse Australian Open pop-up pharmacy[/caption]


Rebecca Davies[/caption]

Professor Clare Collins[/caption]
Associate Professor Trevor Steward[/caption]








